Background: Insulinoma-associated protein 1 (INSM1) has been considered as a novel
immunostain for neuroendocrine tumors (NETs) and is hypothesized to be more reliable …

For the diagnosis and clinical monitoring of NEN, there still exists a considerable need for
better biomarkers. Novel technology has resulted in a promising liquid biopsy for the …

Primary neuroendocrine neoplasm of the breast (PNENB) is a rare subtype of breast cancer,
accounting for< 1% of all breast tumors. The morphological features of PNENB are similar to …

Small cell lung carcinoma (SCLC) is an aggressive and difficult to treat cancer. Although
immunohistochemistry is not mandatory for a SCLC diagnosis, it might be required …

Neuroendocrine carcinomas of the lung are currently classified into two categories: small‐
cell lung carcinoma and large‐cell neuroendocrine carcinoma. Diagnostic criteria for small …

Background: The identification of the causal SNPs of complex diseases in large-scale
genome-wide association analysis is beneficial to the studies of pathogenesis, prevention …

Methods: Hypercellular (Type B) mucinous carcinomas, solid papillary carcinomas, invasive
carcinomas of no special type with neuroendocrine features and ductal carcinomas in situ of …

Introduction: Small cell lung carcinoma (SCLC) is one of the most aggressive, difficult to
diagnose, and difficult to treat forms of cancer. It is part of the extensive group of …

A neuroendokrin daganatok (NEN) a rosszindulatú tumorok közel 1%-át teszik ki. Bármely
szervben kialakulhatnak, azonban a leggyakrabban érintett régiók a tüdő és a …